Mitochondrial medicine

Mitochondrial Medicine: Mitochondrial Metabolism, Diseases, Diagnosis and Therapy

Volumn , Issue , 2008, Pages 103-113

  Gvozdjáková, Anna ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Aging; mitochondrial disease; mitochondrial medicine; oxidative stress

Indexed keywords

EID: 84892085088     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4020-6714-3_5     Document Type: Chapter

References (43)

1. Aliev G, Smith MA, Torre JC, Perry G (2004) Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease. Mitochondrion 4:649-663.
2. Andreson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Derouin J, Eperon IC, Nierlich DP, Roe BA, Sanger F, Schreier PH, Smith AJ, Staden R, Young IG (1981) Sequence and organization of the human mitochondrial genome. Nature 290:457-465.
3. Beal MF (2005) Mitochondria take center stage in ageing and neurodegeneration. Ann Neurol 58(4):495-505.
4. Bota DA, Davies KJA (2001) Protein degradation in mitochondria: Implications for oxidative stress, ageing and diseases: A novel etiological classification of mitochondrial proteolytic disorders (review). Mitochondrion 1:33-49.
5. Browne SE, Beal MF (2004) The energetics of Huntington's disease. Neurochem Res 29(3):531-546.
6. Browne SE, Ferrante RJ, Beal MF (1999) Oxidative stress in Huntington's disease. Brain Pathol 9:147-163.
7. 10 therapy. Biofactors 18:163-171.
8. Dauer W, Przedborski S (2003) Parkinson's disease: mechanisms and models. Neuron 39:889-909.
9. DiMauro S., DiMauro PM (1973) Muscle carnitine palmitoyl-trransferase deficiency and myoglobinuria. Science 182:929-931.
10. Di Mauro, Hirano M., Schon EA (2006). Mitochondrial Medicine. Informa Healthcare 2006, pp 348.
11. Engel AG, Angelini C (1973) Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: A new syndrome. Science 179:899-902.
12. Epstein CJ (1995) Down's syndrome (trisomy 21). In: Scriver CR, Beaudet AL, Sly WS et al. (eds) The Metabolic and Molecular Bases of Inherited Diseases. McGraw-Hill, New York.
13. Fraser PE, Yang DS, Yu G, Lovesque L, Nishimura M, Arawaka S, Serpell LC, Rogaeva E, Hyslop PG (2000) Presenilin structure, function and role in Alzheimer's disease. Biochim Biophys Acta 1502:1-15.
14. Gardian G, Vecsei L (2004) Huntington's disease: pathomechanism and therapeutic perspectives. J Neural Transm 111:1485-1494.
15. Haas RH, Nasirian F, Nakano K et al. (1989) Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol 37:714-722.
16. Hayakawa M, Torii K, Sugiyama S, Tanaka M, Ozawa T (1991) Age-associated accumulation of 8-hydroxydeoxyquanosine in mitochondrial DNA of human diaphragm. Biochem Biophys Res Commun 179(2):1023-1029.
17. Hayakawa M, Katsumata K, Yoneda M, Tanaka M, Sugyiama S, Ozawa T (1996) Agedrelated extensive fragmentation of mitochondrial DNA into minicircles. Biochem Biophys Res Commun 226(2):369-377.
18. Jope R, Blass JP (1975) A comparison of the regulation of pyruvate dehydrogenase in mitochondria from rat brain and liver. Biochem J 150:397-403.
19. 10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease. Neurochem Int 48:93-99.
20. Kim SH, Fountoulakis M, Dierssen M, Lubec G (2001) Decreased protein levels of complex I 30-kDa subunit in fetal Down's syndrome brains. J Neural Transm Suppl 61:109-116.
21. Kunz WS, Kuznetsov AV, Clark JF, Tracey I, Elger CE (1999) Metabolic consequences of the cytochrome c oxidase deficiency in brain of copper-deficient Mo(vbr) mice. J Neurochem 72:1580-1585.
22. Luft R (1994) The development of mitochondrial medicine. Proc Natl Acad Sci USA 91:9831-9838.
23. Luft R, Landau BR (1995) Mitochondrial medicine. J Intern Med 238:405-421.
24. Luft R, Ikkos D, Palmieri G, Ernster L, Afzelius B (1962) A case of severe hypermetabolism of nonthyroid origin with the defect in the maintenance of mitochondrial respiratory control: A correlated clinical, biochemical and morphological study. J Clin Invest 41:1776-1804.
25. Miquel J, Fleming JE (1984) A two-step hypothesis on the mechanism of in vitro cell ageing: cell differentiation followed by intrinsic mitochondrial mutagenesis. Exp Gerontol 19:31-36.
26. Muchová J, Šustrová M, Garaiová I, Liptáková A, Blažíček P, Kvasnička P, Pueschel S, Duračková Z (2001) Influence of age on activities of antioxidant enzymes and lipid peroxidation products in erythrocytes and neutrophils of Down's syndrome patients. Free Radic Biol Med 31(4):499-508.
27. Muller-Hocker J (1989) Cytochrome-c -oxidase deficient cardiomyocytes in the human heart-an age-related phenomenon. A histochemical ultracytochemical study. Am J Pathol 134(5):1167-1173.
28. Naviaux RK (2004) Developing a systematic approach to the diagnosis and classification of mitochondrial disease. Mitochondrion 4:351-361.
29. Pereira C, Gazila MM, Oliviera CR (2001) β-amyloid protein impairs mitochondrial function. In: Ebadi M, Nearwah J, Chopra RK (eds) Mitochondrial Ubiquinone, Vol. 2. pp 281-300.
30. Reddy PH (2006) Mitochondrial oxidative damage in ageing and Alzheimer's disease: Implications for mitochondrially targeted antioxidant therapeutics (review article). J Biomed Biotechnol 31372:1-13.
31. Reddy PH, Beal MF (2005) Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Research. Brain Res Rev 49(3):618-632.
32. Reed JC (2002) Apoptosis-based therapies. Nat Rev/Drug Discov 1:111-121.
33. Remacle J, Lambert D, Raes M, Pigeolet E, Michiels C, Toussaint D (1992) Importance of various antioxidant enzymes for cell stability. Biochem J 286:41-46.
34. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81(2):741-766.
35. Shults CW (2004) Mitochondrial dysfunction and possible treatments in Parkinson's disease-a review. Mitochondrion 4:641-648.
36. 10 in early Parkinson's disease: evidence of slowing of the functional decline. Arch Neurol 59:1541-1550.
37. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G (2002) Oxidative stress in Alzheimer's disease. (Review). Biochim Biophys Acta 1502:139-144.
38. Spiro AJ, Moore CL, Prineas JW, Strasberg PM, Rapin I (1970) A cytochrome-related inherited disorder of the nervous system and muscle. Arch Neurol 23:103-112.
39. Van Gurp M, Festjens N, Van Loo G, Saelens S, Vandenabeele P (2003) Mitochondrial intermembrane proteins in cell death. Biochem Biophys Res Commun 304:487-497.
40. Vielhalber S, Kaufmann J, Kanowski M et al. (2001) Effect of creatine supplementation on metabolite levels in ALS motor cortices. Exp Neurol 172:377-382.
41. Vila M, Przedborski S (2004) Genetic clues to the pathogenesis of Parkinson's disease. Nat Med 10(Suppl):S58-S62.
42. Wallace DC, Singh G, Lott MT, Hodge JA, Schurr TG, Lezza AM, Elsas LJ, Nicoskelainen EK (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 24:21427-21430.
43. Zhang C, Linnane AW, Nagley P (1993) Occurrence of a particular base substitution (3243 A to G) in mitochondrial DNA of tissues of ageing humans. Biochem Biophys Res Commun 195(2):1104-1110.